Sunday, February 13, 2011
Pfizer agrees to pay $330 million to settle cases over drug alleged to cause breat cancer
About a week ago, the Pennsylvania Superior Court issued its decision in a case called Daniel v. Wyeth Pharms., (available here). The Superior Court reversed the trial court’s decision granting Wyeth’s motion for a new trial and reinstated the compensatory and punitive damages verdicts. In response it is now being reported that Pfizer has agreed to pay about $330 million to settle more than 2,200 lawsuits charging its Prempro hormone replacement therapy caused women to develop breast cancer. For more on this story go to Pharmalot. For criticism of the decision go here.